{"id":880,"date":"2025-11-09T00:22:05","date_gmt":"2025-11-09T00:22:05","guid":{"rendered":"https:\/\/femaleswholead.com\/?p=880"},"modified":"2025-11-11T00:22:21","modified_gmt":"2025-11-11T00:22:21","slug":"leen-kawas-on-closing-the-gender-gap-in-venture-funding","status":"publish","type":"post","link":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/","title":{"rendered":"Leen Kawas on Closing the Gender Gap in Venture Funding"},"content":{"rendered":"\n

In a venture ecosystem flooded with capital and fueled by innovation, one imbalance remains stubbornly intact: women founders receive a fraction of available funding. For Leen Kawas, this isn\u2019t just a statistic\u2014it\u2019s a structural problem that limits the very innovation the industry claims to support. As a scientist, biotech entrepreneur, and CEO of EIT Pharma<\/a>, she is building an alternative.<\/p>\n\n\n\n

Kawas\u2019s path into venture was forged through firsthand experience. As co-founder and former CEO of Athira Pharma, she raised over $400 million, took the company public, and joined the ranks of just 22 U.S. women to lead a company through an IPO. That visibility brought its own pressures, but it also granted her clarity. Despite having the data, the clinical assets, and the track record, access to capital remained a battle she had to win repeatedly. And she knew many others wouldn\u2019t get the same chance.<\/p>\n\n\n\n

The gender gap in venture funding is well-documented. In life sciences and biotech, it\u2019s even sharper. Female founders struggle to secure lead investor positions, to be taken seriously in technical diligence, and to navigate networks that still function as closed loops. Leen Kawas<\/a> doesn\u2019t frame this as a bias issue alone. She frames it as a failure of imagination\u2014a missed opportunity to fund companies with different questions, better representation, and often more sustainable models of leadership.<\/p>\n\n\n\n

At Propel Bio Partners, Kawas has helped design a platform that confronts this head-on. The fund backs life science companies with high-impact potential, but it also prioritizes leadership teams that reflect the real world\u2014women, people of color, and scientists whose experience isn\u2019t always polished into investor-ready language. The goal isn\u2019t optics. It\u2019s access. Because the metrics for success don\u2019t change with gender. What changes is who gets in the room.<\/p>\n\n\n\n

Her philosophy is built on proximity. As someone who has sat across from skeptical boards and stood in front of IPO roadshows, Kawas understands what founders need\u2014especially those not groomed by the usual accelerators or venture pedigree. They need capital, yes. But they also need someone who can help translate science into strategy, help anticipate regulatory barriers, and help navigate the social nuances of fundraising when you don\u2019t look like everyone else at the table.<\/p>\n\n\n\n

Kawas emphasizes that closing the gender gap isn\u2019t about loosening standards. It\u2019s about applying the same standards with the same scrutiny to everyone. Too often, female-led companies are judged on risk<\/a>. Male-led companies are judged on potential. Kawas works to flip that script by investing in teams with scientific integrity, clear product-market fit, and operational discipline\u2014while also pushing investors to interrogate their own defaults.<\/p>\n\n\n\n

One of the challenges she names is the false neutrality of venture capital. Firms often insist that they are \u201cfounder-agnostic\u201d or \u201cdata-driven.\u201d But when deal flow is shaped by referrals, pitch introductions, and alumni networks, neutrality becomes a myth. Kawas encourages LPs and GPs alike to audit not just their portfolios, but their patterns\u2014who gets follow-up, who gets coached, and who gets the benefit of the doubt.<\/p>\n\n\n\n

Beyond funding, she believes that mentorship infrastructure is essential. Women founders often lack access to experienced advisors who understand the realities of raising a Series B while also leading a clinical trial team or balancing technical leadership with investor communications. At Propel, portfolio support includes not only capital strategy but also governance, positioning, and scale planning. Kawas doesn\u2019t separate capital from guidance. She knows most founders\u2014especially those breaking the mold\u2014can\u2019t afford to either.<\/p>\n\n\n\n

There is also a generational component to her work. Leen Kawas wants the next wave of women in science and tech<\/a> to see venture not just as a gatekeeping mechanism but as a tool they can master and, eventually, reshape. That means shifting narratives early\u2014training PhDs to think about capitalization, training postdocs to think about leadership, and encouraging women at all stages to think expansively about their place in biotech\u2019s future.<\/p>\n\n\n\n

For Kawas, the gender gap is not just a question of representation. It is a constraint on progress. Ideas are being lost. Products are being delayed. Patients are being underserved. Not because the science isn\u2019t viable\u2014but because the system still filters founders through a narrow lens of credibility.<\/p>\n\n\n\n

Her work at Propel offers an alternative: a structure where merit is still king, but access isn\u2019t pre-filtered. Where diversity isn\u2019t a quota, but a signal of relevance. And where women don\u2019t just get funded\u2014they get built in.<\/p>\n\n\n\n

In Leen Kawas\u2019s view, closing the gender gap isn\u2019t just the right thing to do. It\u2019s the most pragmatic way to accelerate innovation in life sciences. Because better ideas come from more places. And the future of medicine should reflect that.<\/p>\n\n\n\n

Learn more about Leen Kawas\u2019 other work at Inherent Bio<\/a> as a member of the board. <\/p>\n","protected":false},"excerpt":{"rendered":"

In a venture ecosystem flooded with capital and fueled by innovation, one imbalance remains stubbornly intact: women founders receive a fraction of available funding. For Leen Kawas, this isn\u2019t just a statistic\u2014it\u2019s a structural problem that limits the very innovation the industry claims to support. As a scientist, biotech entrepreneur, and CEO of EIT Pharma, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-880","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nLeen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead\" \/>\n<meta property=\"og:description\" content=\"In a venture ecosystem flooded with capital and fueled by innovation, one imbalance remains stubbornly intact: women founders receive a fraction of available funding. For Leen Kawas, this isn\u2019t just a statistic\u2014it\u2019s a structural problem that limits the very innovation the industry claims to support. As a scientist, biotech entrepreneur, and CEO of EIT Pharma, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Females Who Lead\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-09T00:22:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-11T00:22:21+00:00\" \/>\n<meta name=\"author\" content=\"Avery Moore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avery Moore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/\",\"url\":\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/\",\"name\":\"Leen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead\",\"isPartOf\":{\"@id\":\"https:\/\/femaleswholead.com\/#website\"},\"datePublished\":\"2025-11-09T00:22:05+00:00\",\"dateModified\":\"2025-11-11T00:22:21+00:00\",\"author\":{\"@id\":\"https:\/\/femaleswholead.com\/#\/schema\/person\/2647ddcebfef93ba5f8e08f655677b95\"},\"breadcrumb\":{\"@id\":\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/femaleswholead.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leen Kawas on Closing the Gender Gap in Venture Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/femaleswholead.com\/#website\",\"url\":\"https:\/\/femaleswholead.com\/\",\"name\":\"Females Who Lead\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/femaleswholead.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/femaleswholead.com\/#\/schema\/person\/2647ddcebfef93ba5f8e08f655677b95\",\"name\":\"Avery Moore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/femaleswholead.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/84cf82064ca1f71156ea2a20d2b2dfa3d2f4fb7268b8197bd608cafc2df9a0c1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/84cf82064ca1f71156ea2a20d2b2dfa3d2f4fb7268b8197bd608cafc2df9a0c1?s=96&d=mm&r=g\",\"caption\":\"Avery Moore\"},\"sameAs\":[\"https:\/\/femaleswholead.com\"],\"url\":\"https:\/\/femaleswholead.com\/index.php\/author\/admin_gjruvwqo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/","og_locale":"en_US","og_type":"article","og_title":"Leen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead","og_description":"In a venture ecosystem flooded with capital and fueled by innovation, one imbalance remains stubbornly intact: women founders receive a fraction of available funding. For Leen Kawas, this isn\u2019t just a statistic\u2014it\u2019s a structural problem that limits the very innovation the industry claims to support. As a scientist, biotech entrepreneur, and CEO of EIT Pharma, […]","og_url":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/","og_site_name":"Females Who Lead","article_published_time":"2025-11-09T00:22:05+00:00","article_modified_time":"2025-11-11T00:22:21+00:00","author":"Avery Moore","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avery Moore","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/","url":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/","name":"Leen Kawas on Closing the Gender Gap in Venture Funding - Females Who Lead","isPartOf":{"@id":"https:\/\/femaleswholead.com\/#website"},"datePublished":"2025-11-09T00:22:05+00:00","dateModified":"2025-11-11T00:22:21+00:00","author":{"@id":"https:\/\/femaleswholead.com\/#\/schema\/person\/2647ddcebfef93ba5f8e08f655677b95"},"breadcrumb":{"@id":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/femaleswholead.com\/index.php\/2025\/11\/09\/leen-kawas-on-closing-the-gender-gap-in-venture-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/femaleswholead.com\/"},{"@type":"ListItem","position":2,"name":"Leen Kawas on Closing the Gender Gap in Venture Funding"}]},{"@type":"WebSite","@id":"https:\/\/femaleswholead.com\/#website","url":"https:\/\/femaleswholead.com\/","name":"Females Who Lead","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femaleswholead.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/femaleswholead.com\/#\/schema\/person\/2647ddcebfef93ba5f8e08f655677b95","name":"Avery Moore","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/femaleswholead.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/84cf82064ca1f71156ea2a20d2b2dfa3d2f4fb7268b8197bd608cafc2df9a0c1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84cf82064ca1f71156ea2a20d2b2dfa3d2f4fb7268b8197bd608cafc2df9a0c1?s=96&d=mm&r=g","caption":"Avery Moore"},"sameAs":["https:\/\/femaleswholead.com"],"url":"https:\/\/femaleswholead.com\/index.php\/author\/admin_gjruvwqo\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/posts\/880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/comments?post=880"}],"version-history":[{"count":1,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/posts\/880\/revisions"}],"predecessor-version":[{"id":881,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/posts\/880\/revisions\/881"}],"wp:attachment":[{"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/media?parent=880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/categories?post=880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femaleswholead.com\/index.php\/wp-json\/wp\/v2\/tags?post=880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}